Publication | Open Access

Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer

Phase I/ii StudyMedicineMetronomic TherapyPediatricsPediatric OncologyWeekly Nab-paclitaxelCancer TreatmentOncologyCancer ResearchRecurrent/refractory Solid Tumours